These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25781318)

  • 21. Editorial: Integrative Approach to Manage Neurological Disorders.
    Zargaran A
    Curr Drug Metab; 2018; 19(5):384. PubMed ID: 29788866
    [No Abstract]   [Full Text] [Related]  

  • 22. Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders.
    Ye N; Neumeyer JL; Baldessarini RJ; Zhen X; Zhang A
    Chem Rev; 2013 May; 113(5):PR123-78. PubMed ID: 23464812
    [No Abstract]   [Full Text] [Related]  

  • 23. Adult neurogenesis pharmacology in neurological diseases and disorders.
    Taupin P
    Expert Rev Neurother; 2008 Feb; 8(2):311-20. PubMed ID: 18271715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quinolinic acid in neurological disease: opportunities for novel drug discovery.
    Reinhard JF; Erickson JB; Flanagan EM
    Adv Pharmacol; 1994; 30():85-127. PubMed ID: 7833298
    [No Abstract]   [Full Text] [Related]  

  • 25. The significance of the "dying back" process in experimental and human neurological disease.
    Cavanagh JB
    Int Rev Exp Pathol; 1964; 3():219-67. PubMed ID: 5317971
    [No Abstract]   [Full Text] [Related]  

  • 26. Targeting voltage-gated calcium channels in neurological and psychiatric diseases.
    Zamponi GW
    Nat Rev Drug Discov; 2016 Jan; 15(1):19-34. PubMed ID: 26542451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transporters as Drug Targets in Neurological Diseases.
    Qosa H; Mohamed LA; Alqahtani S; Abuasal BS; Hill RA; Kaddoumi A
    Clin Pharmacol Ther; 2016 Nov; 100(5):441-453. PubMed ID: 27447939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Editorial (Thematic Issue: From Old Cannabinoids to Emerging New Synthetic Derivatives with Potential Therapeutic Application in Neurological Disorders).
    Malfitano AM
    Recent Pat CNS Drug Discov; 2016; 10(2):75. PubMed ID: 27875961
    [No Abstract]   [Full Text] [Related]  

  • 29. Tocotrienols: potential drug targets for cardiovascular, cancer and neurological diseases.
    Das DK
    Curr Pharm Des; 2011; 17(21):2145-6. PubMed ID: 21774777
    [No Abstract]   [Full Text] [Related]  

  • 30. Rapamycin: one drug, many effects.
    Li J; Kim SG; Blenis J
    Cell Metab; 2014 Mar; 19(3):373-9. PubMed ID: 24508508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editorial.
    Saarma M; Castrén E; Runeberg-Roos P
    Neurobiol Dis; 2017 Jan; 97(Pt B):71-72. PubMed ID: 27938864
    [No Abstract]   [Full Text] [Related]  

  • 32. The promise of minocycline in neurology.
    Yong VW; Wells J; Giuliani F; Casha S; Power C; Metz LM
    Lancet Neurol; 2004 Dec; 3(12):744-51. PubMed ID: 15556807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editorial: Effective and Promising Treatments for Neurological Disorders and Cancer.
    Uteshev VV
    Curr Pharm Des; 2016; 22(14):1979-80. PubMed ID: 26899733
    [No Abstract]   [Full Text] [Related]  

  • 34. Unravelling neurological disorders through metallomics-based approaches.
    de Jesus JR; Arruda MAZ
    Metallomics; 2020 Dec; 12(12):1878-1896. PubMed ID: 33237082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [KCC2: a new therapeutical target for the treatment of neurological diseases].
    Bergeron MJ; Castonguay A; De Koninck Y
    Med Sci (Paris); 2014 May; 30(5):514-7. PubMed ID: 24939537
    [No Abstract]   [Full Text] [Related]  

  • 36. The Chemical Biology of Ferroptosis in the Central Nervous System.
    Ratan RR
    Cell Chem Biol; 2020 May; 27(5):479-498. PubMed ID: 32243811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Promise and Perils of Compound Discovery Screening with Inducible Pluripotent Cell-Derived Neurons.
    Sharlow ER; Koseoglu MM; Bloom GS; Lazo JS
    Assay Drug Dev Technol; 2020; 18(2):97-103. PubMed ID: 31095406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Autophagy Signaling Pathway: A Potential Multifunctional Therapeutic Target of Curcumin in Neurological and Neuromuscular Diseases.
    Perrone L; Squillaro T; Napolitano F; Terracciano C; Sampaolo S; Melone MAB
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31412596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of MeCP2 in neurological disorders: current status and future perspectives.
    Ausió J
    Epigenomics; 2018 Jan; 10(1):5-8. PubMed ID: 29172690
    [No Abstract]   [Full Text] [Related]  

  • 40. Roles of TRP Channels in Neurological Diseases.
    Wang R; Tu S; Zhang J; Shao A
    Oxid Med Cell Longev; 2020; 2020():7289194. PubMed ID: 32963700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.